NCT00863551View on ClinicalTrials.gov

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

PHASE4CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

ElderlyPharmacokineticsOveractive Bladder

Interventions

DRUG

Trospium Chloride

Extended release, 60 mg, oral daily

Trial Locations (1)

Unknown

Glendale

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY

NCT00863551 - Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial | Biotech Hunter | Biotech Hunter